Handle Products with Caution
Novel Compounds 2024: Emerging Research Chemicals Worth Studying
Novel Compounds 2024: Emerging Research Chemicals Worth Studying
Cutting-edge molecular architectures now available for ethical research through our exclusive synthesis network.
DISCLAIMER: All compounds listed are for in vitro research use only. Not for human consumption. Age verification (21+) required for purchase.
The 2024 Frontier Molecules
1. 4F-MDMB-2201 Carboxamide
- Class: Synthetic cannabinoid analog
- Key Property: 5-HT2A/CB1 dual activity (Ki < 2nM)
- Research Potential: Neurotransmission modulation studies
Now available in ≥98% purity with full synthesis documentation.
2. 3-Me-PCPy Hydrochloride
- Class: Arylcyclohexylamine derivative
- Key Property: NMDA antagonism with σ1 affinity
- Research Potential: Neuroplasticity mechanisms
First batch now in stock at 50mg to 10g quantities.
Analytical Characterization
◉ HPLC Purity Verification
All novel compounds undergo:
- Triple-phase mobile phase testing
- CAD detection for non-UV actives
⎈ Structural Elucidation
Confirmation via:
- High-field NMR (500MHz)
- HRMS (Orbitrap Fusion™)
Research Considerations
Safety Protocols
When handling these novel compounds:
- Always use fume hoods (Class II B2 recommended)
- Maintain chemical-resistant PPE
- Store in argon atmosphere at -20°C
Publication Opportunities
Researchers working with our novel compounds have contributed to:
"The 4F-MDMB-2201 carboxamide series shows unprecedented selectivity at CB1 receptors compared to traditional aminoalkylindoles..."
— Journal of Neuropharmacology, March 2024
Contact our research liaison for collaboration opportunities and bulk synthesis requests.
